Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 3/20 | 0.41 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.35 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.35 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.35 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.33 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.33 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.33 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15948146 | 0.97 | AKR1B1 (0.39) | AKR1B1TAS1R3TAS1R1TAS1R2FOLH1 | |
| SCHEMBL15948192 | 0.97 | AKR1B1 (0.42) | AKR1B1TAS1R3TAS1R1TAS1R2FOLH1 | |
| SCHEMBL15948206 | 0.94 | AKR1B1 (0.41) | AKR1B1TAS1R3TAS1R1TAS1R2FOLH1 | |
| SCHEMBL4103547 | 0.85 | IMPDH2 (0.39) | AKR1B1TAS1R3TAS1R1TAS1R2KDM4E | |
| SCHEMBL11268242 | 0.85 | CYP1A2 (0.37) | AKR1B1HSD17B10CA2CYP1A2 | |
| SCHEMBL27762098 | 0.85 | CSNK2A2 (0.41) | AKR1B1TAS1R3TAS1R1TAS1R2MEN1 | |
| SCHEMBL4674767 | 0.83 | DUSP3 (0.35) | AKR1B1FOLH1MEN1KMT2A | |
| SCHEMBL29142080 | 0.81 | SMN1; SMN2 (0.53) | AKR1B1MEN1KMT2ATSHRAGBL2 | |
| SCHEMBL12445751 | 0.79 | CYP1A2 (0.37) | AKR1B1KDM4EALDH1A1GAAGLA | |
| SCHEMBL22344509 | 0.79 | AKR1B1 (0.35) | AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 301 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| CN-120199973-A | Polyvinylidene fluoride composite diaphragm for zinc battery and preparation method and application thereof | 中国科学院赣江创新研究院 | 2025-06-24 | — | — | CN | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| CN-118290254-A | Rare earth complex for zinc battery electrolyte and preparation method and application thereof | 中国科学院赣江创新研究院 | 2024-07-05 | — | — | CN | claimed |
| CN-115939514-A | Hydrolysis-resistant functional additive, preparation method thereof and application thereof in solid electrolyte | 华南理工大学 | 2023-04-07 | — | — | CN | claimed |
| CN-111135810-B | Preparation method of special chromatographic separation medium for cannabidiol separation | 苏州汇通色谱分离纯化有限公司 | 2022-08-23 | — | — | CN | claimed |
| WO-2022163846-A1 | NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE | 第一三共株式会社 | 2022-08-04 | — | — | WO | claimed |
| CN-111135810-A | Preparation method of special chromatographic separation medium for cannabidiol separation | 苏州汇通色谱分离纯化有限公司 | 2020-05-12 | — | — | CN | claimed |
| EP-3114715-B1 | P-DOPING CROSS-LINKING OF ORGANIC HOLE TRANSPORTERS | SIEMENS AG (DE) | 2019-10-30 | — | — | EP | claimed |
| EP-1051506-B2 | PROCEDURES FOR THE EXTRACTION AND ISOLATION OF BACTERIAL CAPSULAR POLYSACCHARIDES FOR USE AS VACCINES OR LINKED TO PROTEINS AS CONJUGATES VACCINES | PFIZER IRELAND PHARMACEUTICALS (IE) | 2019-08-21 | — | — | EP | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-6946025-B2 | Process for preparing tetra-amide compounds | XEROX CORPORATION (US) | 2005-09-20 | — | — | US | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| EP-0705279-B1 | TOPOLOGICALLY SEGREGATED, ENCODED SOLID PHASE LIBRARIES | SELECTIDE CORP (US) | 2003-02-19 | — | — | EP | claimed |
| EP-1022952-A4 | HIGH PURITY ALKOXYTRIMETHYLSILANE FLUIDS | CLARIANT LSM ITALIA SPA (US) | 2002-08-14 | — | — | EP | claimed |
| EP-1022952-A1 | HIGH PURITY ALKOXYTRIMETHYLSILANE FLUIDS | ARCHIMICA (FLORIDA), Inc. (US) | 2000-08-02 | — | — | EP | claimed |
| WO-1999017615-A1 | HIGH PURITY ALKOXYTRIMETHYLSILANE FLUIDS | ARCHIMICA (FLORIDA) INC. (US) | 1999-04-15 | — | — | WO | claimed |
| US-5847179-A | High purity alkoxytrimethylsilane fluids | PCR, INC. (US) | 1998-12-08 | — | — | US | claimed |
| US-5750568-A | DITERPENE PHORBOIDS | PROCYON PHARMACEUTICALS, INC. (US) | 1998-05-12 | — | — | US | claimed |
| US-5214218-A | Montmorillonite clays | TEXACO CHEMICAL COMPANY (US) | 1993-05-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | AKR1B1 1963/4885TAS1R3 1889/4885TAS1R1 2623/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | AKR1B1 2784/4885TAS1R3 1031/4885TAS1R1 1032/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.